⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2374690 | 0.90 | — | — | |
| SCHEMBL1170221 | 0.87 | GPR84 (0.39) | — | |
| SCHEMBL1957878 | 0.87 | GPR84 (0.39) | — | |
| SCHEMBL1958836 | 0.87 | GPR84 (0.39) | — | |
| SCHEMBL3127999 | 0.87 | GPR84 (0.39) | — | |
| SCHEMBL973119 | 0.87 | — | — | |
| SCHEMBL6125503 | 0.87 | — | — | |
| SCHEMBL8920113 | 0.87 | GPR84 (0.39) | — | |
| SCHEMBL3124517 | 0.87 | GPR84 (0.39) | — | |
| SCHEMBL1961525 | 0.87 | GPR84 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240150285-A1 | MODULATORS OF COMPLEX I | BOEHRINGER INGELHEIM INT (DE) | 2024-05-09 | — | — | US | claimed |
| CN-117916385-A | Novel process for the production of poly-4-hydroxybutyrate and 1, 4-butanediol | CJ第一制糖株式会社 | 2024-04-19 | — | — | CN | claimed |
| EP-4349994-A1 | NOVEL METHOD FOR PRODUCING POLY-4-HYDROXYBUTYRATE AND 1,4-BUTANEDIOL | CJ Cheiljedang Corporation (KR) | 2024-04-10 | — | — | EP | claimed |
| EP-4291552-A1 | MODULATORS OF COMPLEX I | Boehringer Ingelheim International GmbH (DE) | 2023-12-20 | — | — | EP | claimed |
| CN-117120476-A | Antibodies specific for structurally disordered sequences | XL-普洛坦公司 | 2023-11-24 | — | — | CN | claimed |
| EP-4267628-A1 | ANTIBODIES SPECIFIC FOR STRUCTURALLY DISORDERED SEQUENCES | XL-protein GmbH (DE) | 2023-11-01 | — | — | EP | claimed |
| US-11795147-B2 | Modulators of complex I | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2023-10-24 | — | — | US | claimed |
| CN-116848101-A | Modulators of complex I | 勃林格殷格翰国际有限公司 | 2023-10-03 | — | — | CN | claimed |
| US-11767521-B2 | Genetically modified bacterial cells and methods useful for producing indigoidine | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-09-26 | — | — | US | claimed |
| EP-3368548-B1 | METHANOL DEHYDROGENASE FUSION PROTEINS | GENOMATICA INC (US) | 2023-08-23 | — | — | EP | claimed |
| WO-1984004303-A1 | NEW OCTAHYDROBENZO (f) QUINOLINE DERIVATIVES | ASTRA LAEKEMEDEL AB (SE) | 1984-11-08 | — | — | WO | claimed |
| US-4464393-A | Use of alkanoyl L-carnitines in the therapeutical treatment of myopathies and muscular dystrophies | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1984-08-07 | — | — | US | claimed |
| US-4362719-A | INSULIN, MIXTURES | CAVAZZA CLAUDIO | 1982-12-07 | — | — | US | claimed |
| US-4346107-A | SENILITY | Cavazza, Claudio (IT) | 1982-08-24 | — | — | US | claimed |
| US-4343816-A | Pharmaceutical composition comprising an acyl-carnitine, for treating peripheral vascular diseases | CAVAZZA CLAUDIO | 1982-08-10 | — | — | US | claimed |
| US-4330557-A | UPGRADING METABOLIC OXIDATION OF FATTY ACIDS IN HUMANS | CAVAZZA CLAUDIO | 1982-05-18 | — | — | US | claimed |
| US-4320145-A | Pharmaceutical composition for parenteral nutrition comprising L-carnitine or acyl L-carnitines | SIGMA-TAU INC. | 1982-03-16 | — | — | US | claimed |
| US-4268524-A | Method of treating abnormal lipoprotein ratios with acylcarnitine | CAVAZZA CLAUDIO | 1981-05-19 | — | — | US | claimed |
| US-4237167-A | Acyl-carnitines in a therapeutical method for treating chronic uraemic patients undergoing regular dialysis and liquid composition for use therein | CAVAZZA CLAUDIO | 1980-12-02 | — | — | US | claimed |
| US-4194006-A | ANTIARRHYTHMIA | CAVAZZA CLAUDIO (IT) | 1980-03-18 | — | — | US | claimed |